Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Rachel explains how reoccurring UTIs devastated her life…

As a final year PhD student in Pharmaceutical Science and a BSAC member, Paul-Enguerrand Fady was more used to working in a laboratory, sitting at a biological safety cabinet, peering down at tubes and plates. That was until last October, when he started working one day a week in the House of Lords. In this short blog, he explains how he ended up in Parliament, and what he’s learned during his time there…

After a two-year hiatus due to covid, BSAC’s legendary Antibiotic Resistance and Mechanisms Workshop for Researchers (ARM) is back! Here, Andy Edwards & Michelle Buckner Chairs of ARM’s Programme Committee, explain what this unique annual event means to them… and why it’s unmissable for early-career researchers.

Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Annabelle explains how a superbug infection took hold following a horse-riding accident.

Antimicrobial Resistance (AMR) is one of the world’s leading causes of illness and death, causing misery to millions every year. As part of a new series, we are featuring stories of patients who have been affected by AMR, as told to Antibiotic Research UK. In this story, Ronda’s experience of how a catheter-acquired UTI after surgery has become resistant to antibiotic treatment and changed her life completely.

Ahead of our forthcoming ‘Into Clinical Practice: Pneumonia’ conference, Professor Mervyn Singer, Professor of Intensive Care Medicine & Chair of the International Sepsis Forum, University College London and Dr Ron Daniels BEM, Executive Director of the UK Sepsis Trust, discuss the challenge of balancing the risk of sepsis with the threat of antimicrobial resistance (AMR).

Infectious intestinal diseases affect 1 in 5 people in the UK each year. Ahead of her talk at BSAC’s upcoming Infection Clinical Dilemmas webinar, Marisa Lanzman explores her thoughts and opinions on this important and sometimes controversial topic.

Drug resistant infections and the superbugs that cause them are an increasing challenge for health systems, globally. The technical term is antimicrobial resistance (AMR), which occurs when microorganisms evolve to resist medicines, represents an exceptional and growing threat to the way we treat diseases, to the way we are enabled to perform routine surgeries and to the way we roll out treatments when we temporarily suppress the immune system, including chemotherapy.